ClinicalTrials.gg
CompletedNCT07643324Updated Nov 18, 2026

Normal vs Low Tidal Volume Ventilation in Retrograde Intrarenal Surgery

An interventional study of low tidal volume ventilation in Renal Calculi, sponsored by Hitit University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Hitit University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 18, 2026Now CompletedPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Kidney Calculi with a site in Turkey — 21 open to participants now, 22 under way, none of them phase 3. Kidney Calculi · Turkey.

Enrollment
27th of 35
60 · median 90
Started
2026
with 13 others
No phase
32 of 48
15 open now
Registered
39th of 48
by date
Lead sponsor
5 of 48
Hitit University

Among the 48 studies in Kidney Calculi with a site in Turkey, this one is the 27th largest by enrollment of the 35 interventional ones that give a count, is one of 14 that started in 2026, is one of 32 with no phase, and was the 39th registered.

Kidney Calculi

510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.

Browse Kidney Calculi studies →

Open to participants now

21 of the 48 studies in Kidney Calculi with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 21 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Kidney Calculi with a site in Turkey, or all of them as a file.
02

Study summary

Retrograde intrarenal surgery is commonly performed under general anesthesia for the treatment of renal stones. During the procedure, respiratory-related renal movement caused by positive-pressure ventilation may impair endoscopic image stability and reduce the efficiency of laser lithotripsy. This randomized controlled trial aims to compare the effects of normal ventilation and low tidal volume ventilation on intraoperative endoscopic image stability during RIRS using a video-based Motion Index.

Eligible adult patients scheduled for elective RIRS under general anesthesia will be randomized in a 1:1 ratio to either normal tidal volume ventilation or low tidal volume ventilation. A standardized 60-second intraoperative video segment in which the stone and/or active laser lithotripsy is visible will be analyzed by blinded assessors. The primary outcome is the mean Motion Index value calculated from sequential video frames. Secondary outcomes include additional Motion Index parameters, laser activation time, anesthesia and surgical duration, intraoperative respiratory and hemodynamic safety parameters, vasopressor requirement, complications, and stone-free status at routine follow-up.

Read the detailed description

Retrograde intrarenal surgery (RIRS) is a minimally invasive endourological procedure widely used for the treatment of renal stones. Because the procedure is performed within the narrow collecting system of the kidney, endoscopic image stability is important for accurate laser targeting, efficient lithotripsy, and procedural safety. During general anesthesia, positive-pressure ventilation may cause diaphragmatic and respiratory-related renal movement, resulting in micro-movements of the endoscopic image. These movements may interfere with continuous laser targeting and may reduce procedural efficiency.

This study is designed as a single-center, prospective, randomized, parallel-group, assessor-blinded controlled trial. Adult patients scheduled for elective RIRS under general anesthesia will be enrolled after obtaining written informed consent. Participants will be randomized in a 1:1 ratio to one of two intraoperative ventilation strategies: normal tidal volume ventilation or low tidal volume ventilation. Randomization will be performed using a computer-generated randomization list, and allocation concealment will be ensured with sequentially numbered, opaque, sealed envelopes. The video assessors will be blinded to group allocation.

After induction of general anesthesia and endotracheal intubation, mechanical ventilation will be standardized according to the assigned group. In the normal ventilation group, tidal volume will be set at 6-8 mL/kg predicted body weight with 5 cmH₂O PEEP. In the low tidal volume ventilation group, tidal volume will be set at 4-6 mL/kg predicted body weight with 5 cmH₂O PEEP. In both groups, respiratory rate will be titrated to maintain EtCO₂ within the target range of 35-45 mmHg, and FiO₂ will be adjusted to maintain SpO₂ above 94%. Patient safety will take priority throughout the study, and ventilation settings may be modified if clinically required. Any protocol deviations will be recorded.

Intraoperative endoscopic videos obtained during routine RIRS will be used for the video-based analysis. After the procedure, video files will be anonymized and coded in a way that does not reveal group allocation. A standardized 60-second segment in which the stone is clearly visible and/or laser lithotripsy is active will be selected according to predefined criteria. The selected segments will be analyzed using a phase-correlation-based image registration method. Sequential video frames will be converted to grayscale, mild noise reduction will be applied, and horizontal and vertical image displacement between consecutive frames will be calculated. The Motion Index will be derived from these displacement components for each frame pair, generating a time series for each patient.

The primary outcome of the study is the mean Motion Index value calculated from the standardized intraoperative video segment. Secondary outcomes include additional Motion Index parameters, including median, 95th percentile, and maximum Motion Index values; laser activation time; anesthesia duration; surgical duration; intraoperative respiratory and hemodynamic parameters such as EtCO₂, SpO₂, mean arterial pressure, heart rate, airway pressures when available, and vasopressor requirement; perioperative complications; and stone-free status at routine postoperative follow-up, planned at approximately 4 weeks.

The study aims to determine whether low tidal volume ventilation improves endoscopic image stability during RIRS without compromising respiratory or hemodynamic safety. The findings may contribute to the standardization of anesthetic ventilation strategies during endourological stone surgery and may provide an objective, reproducible method for evaluating respiratory-related image motion during RIRS.

03

Conditions studied

  • Renal Calculi

Browse trials for

Keywords

  • General anesthesia
  • Retrograde intrarenal surgery
  • Low tidal volume ventilation
  • Video-based image analysis
  • Endoscopic visualization quality
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged 18 years or older
  • Patients scheduled for elective retrograde intrarenal surgery under general anesthesia
  • I-III
  • Patients who are able to read and understand the form
  • Patients who provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years
  • Pregnancy
  • Emergency surgery
  • Severe , severe restrictive pulmonary disease, or preoperative hypercapnia
  • Severe uncontrolled cardiovascular disease
  • Active urinary tract infection, sepsis, or untreated infectious focus
  • Cases in whom the standardized ventilation protocol is difficult to apply because of morbid obesity
  • Patients scheduled for an additional major urological procedure in the same session
  • Cases in which an intraoperative video recording of sufficient quality cannot be obtained
  • Patients in whom the study protocol cannot be safely continued according to the investigator's clinical judgment
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Normal Tidal Volume Ventilation

    Participants in this group will receive standard mechanical ventilation after induction of general anesthesia and endotracheal intubation during retrograde intrarenal surgery. Tidal volume will be set at 6-8 mL/kg predicted body weight with 5 cmH₂O PEEP. Respiratory rate will be titrated to maintain EtCO₂ between 35 and 45 mmHg, and FiO₂ will be adjusted to maintain SpO₂ above 94%.

    Procedure: low tidal volume ventilation

  • Experimental
    Low Tidal Volume Ventilation

    Participants in this group will receive low tidal volume mechanical ventilation after induction of general anesthesia and endotracheal intubation during retrograde intrarenal surgery. Tidal volume will be set at 4-6 mL/kg predicted body weight with 5 cmH₂O PEEP. Respiratory rate will be titrated to maintain EtCO₂ between 35 and 45 mmHg, and FiO₂ will be adjusted to maintain SpO₂ above 94%.

    Procedure: low tidal volume ventilation

Interventions

  • Procedurelow tidal volume ventilation

    Participants allocated to the normal tidal volume ventilation group will receive volume-controlled mechanical ventilation during retrograde intrarenal surgery under general anesthesia. Tidal volume will be set at 6-8 mL/kg predicted body weight with 5 cmH₂O PEEP. Respiratory rate will be titrated to maintain EtCO₂ between 35 and 45 mmHg, and FiO₂ will be adjusted to maintain SpO₂ above 94%.

    Also known as: Normal Tidal Volume Ventilation

06

What researchers measure

Primary outcomes

  1. Mean Motion Index During Retrograde Intrarenal Surgery

    Mean Video-Based Motion Index will be calculated from a standardized 60-second intraoperative endoscopic video segment in which the stone is clearly visible and/or laser lithotripsy is active. The Video-Based Motion Index is a unitless image-motion metric derived from horizontal and vertical frame-to-frame displacement between consecutive video frames using a phase-correlation-based image registration method. The theoretical minimum value is 0, indicating no detected image displacement. There is no predefined fixed maximum value because the value depends on the magnitude of frame-to-frame displacement. Higher values indicate greater endoscopic image motion and worse image stability.

    Time frame: Intraoperative period, during a standardized 60-second video segment

07

Study locations

1 site
  • Hitit university
    Çorum, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to privacy, confidentiality, and institutional ethical restrictions. De-identified data may be made available from the principal investigator upon reasonable request and with appropriate institutional permission.

No publications or documents are linked to this record.

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Oct 2026, 4 months.

Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's 4 months is below that.

Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.

Start moved once since we started tracking on Sep 25, 2026: Apr 2026 → Jun 2026, on Oct 15, 2026.

Primary completion moved twice since we started tracking on Sep 25, 2026: Aug 2026 → Oct 2026, last on Nov 18, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, last on Nov 18, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 8, 2026
First posted
Jun 11, 2026
StartActual
Jun 11, 2026was Apr 2026
Primary completionActual
Oct 20, 2026was Aug 2026
CompletionActual
Nov 2, 2026was Sep 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 3, 2026
Start date
Apr 29, 2026→Jun 11, 2026
Oct 15, 2026
Primary completion
Aug 15, 2026→Oct 20, 2026
moved 2 times, Oct 15, 2026 – Nov 18, 2026
Study completion
Sep 1, 2026→Nov 2, 2026
moved 2 times, Oct 15, 2026 – Nov 18, 2026
Show all 3 updates
  1. Nov 18, 2026
    Primary completion Oct 9, 2026→Oct 20, 2026
    Study completion Oct 15, 2026→Nov 2, 2026
  2. Nov 3, 2026
    Recruiting→Completed
    + 4 other changes: verification date, date precision, contact details and site details
  3. Oct 15, 2026
    Start date Apr 29, 2026→Jun 11, 2026
    Primary completion Aug 15, 2026→Oct 9, 2026 (now actual)
    Study completion Sep 1, 2026→Oct 15, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07643324
Lead sponsor
Hitit University
Responsible party
Sibel Onen Ozdemir (Medical Doctor, Hitit University) — Principal investigator
First posted
Jun 11, 2026
Start date
Jun 11, 2026
Primary completion
Oct 20, 2026
Completion
Nov 2, 2026
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion